Check a product
Search or scan any product against every CPSC, FDA, USDA, and NHTSA recall on record — or read the last 90 days below.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Gourmet Foods Masala Chaash Lassi recalled for pasteurization risk
Joy Gourmet Foods LLC is recalling Masala Chaash Lassi in 16 oz. and 64 oz. bottles because the product was not adequately pasteurized. Unpasteurized dairy products can contain harmful bacteria that may cause illness. The affected bottles have expiration dates between June 30 and July 30, 2026.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Plain Chaash Lassi recalled for inadequate pasteurization
Joy Gourmet Foods LLC is recalling Plain Chaash Lassi in 16 oz. and 64 oz. bottles because the product was not adequately pasteurized, which means it may contain harmful bacteria. The affected products have expiration dates between June 30 and July 30, 2026, and were distributed in New York, New Jersey, and Pennsylvania.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Mango-Pina-Orange Lassi recalled for inadequate pasteurization
Joy Gourmet Foods LLC is recalling Mango-Pina-Orange Lassi in 16 oz. and 64 oz. bottles because the product was not adequately pasteurized. Inadequate pasteurization can allow harmful bacteria to survive in the beverage.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Gourmet Mango-Pina-Strawberry Lassi recalled for pasteurization risk
Joy Gourmet Foods' Mango-Pina-Strawberry Lassi (16 oz bottles) was not adequately pasteurized during production. Inadequate pasteurization can allow harmful bacteria to survive, posing a food safety risk. The affected product has expiration dates between June 30 and July 30, 2026, and was distributed in New York, New Jersey, and Pennsylvania.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Strawberry Lassi recalled for inadequate pasteurization
Joy Strawberry Lassi 16 oz. bottles were not adequately pasteurized, which means they may not have been heated sufficiently to kill harmful bacteria. The affected product was distributed in New York, New Jersey, and Pennsylvania, with expiration dates between June 30 and July 30, 2026.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Pineapple Lassi recalled for inadequate pasteurization
Joy Gourmet Foods LLC recalled 16 oz bottles of Joy Pineapple Lassi because the product was not adequately pasteurized. This means harmful bacteria may not have been fully eliminated during processing. The affected bottles were distributed in New York, New Jersey, and Pennsylvania with expiration dates between June 30 and July 30, 2026.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Gourmet Foods salty lassi recalled for pasteurization risk
Joy Gourmet Foods LLC's 16 oz. salty lassi product was not adequately pasteurized during production. The affected bottles have expiration dates between June 30 and July 30, 2026. No illnesses have been reported.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Gourmet Foods Sweet Lassi recalled for pasteurization risk
Joy Gourmet Foods Sweet Lassi 16 oz. was not adequately pasteurized, which means it may contain harmful bacteria. The affected product has expiration dates between June 30 and July 30, 2026, and was distributed in New York, New Jersey, and Pennsylvania.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Rose Lassi recalled for inadequate pasteurization
Joy Gourmet Foods' Rose Lassi drink (16 oz bottles) was not adequately pasteurized during production. This means harmful bacteria may not have been fully eliminated. The affected product was distributed in New York, New Jersey, and Pennsylvania, with expiration dates between June 30 and July 30, 2026.
- 2026-07-01FDA-FoodJoy Gourmet Foods LLC.Class IIJoy Mango Lassi recalled for inadequate pasteurization
Joy Gourmet Foods' mango lassi (16 oz. and 64 oz. bottles) was not adequately pasteurized during manufacturing. Inadequate pasteurization can allow harmful bacteria to survive in the product. Affected bottles have expiration dates between June 30 and July 30, 2026.
- 2026-07-01FDA-FoodPrime Food Processing LLC.Class IPrime Food Processing dried herring recalled for botulism risk
Prime Food Processing dried herring fish (7 oz.) was not properly cleaned before drying, which can allow Clostridium botulinum bacteria to grow. This bacterium produces a toxin that causes botulism, a serious foodborne illness. The affected product has lot code 26020 with expiration date 06.12.28.
- 2026-07-01FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IISun Pharmaceutical Perampanel recalled for tablet strength mix-up
Sun Pharmaceutical discovered that some bottles labeled as containing 6mg Perampanel tablets actually contained 10mg tablets instead. This mix-up affects one lot (AE01763) distributed nationwide. Patients taking the wrong strength could receive an incorrect dose of this seizure medication.
- 2026-07-01FDA-DrugElevate Oral CareClass IIElevate Oral Care Povi-One recalled for sub-potency
Elevate Oral Care's Povi-One 10% Povidone-Iodine Oral Antiseptic does not contain the full strength stated on the label. Five specific production lots distributed nationwide do not meet the required potency standard, which means the product may not work as intended for oral antiseptic purposes.
- 2026-07-01FDA-DrugAnnora Pharma Private LimitedClass IICamber Lacosamide tablets recalled for Selexipag mix-up
Some bottles of Lacosamide 100mg tablets may contain Selexipag 1000 mcg tablets instead. This mix-up happened during manufacturing and could cause patients to take the wrong medication. The recall affects specific lots distributed nationwide.
- 2026-07-01FDA-DrugCareFusion 213, LLCClass IBD ChloraPrep FREPP Clear recalled for sterility concerns
BD ChloraPrep FREPP Clear, a sterile skin antiseptic applicator, may contain fungal contamination (Aspergillus penicillioides) or may not be fully sterile due to wrinkles in the packaging seal. Approximately 178,000 applicators from lot 4073005 (expiring 03/31/2027) are affected nationwide and internationally.
- 2026-07-01FDA-DrugCareFusion 213, LLCClass IBD ChloraPrep Clear recalled for fungal contamination risk
BD ChloraPrep Clear, a sterile antiseptic skin-prep solution used before medical procedures, was found to contain Aspergillus penicillioides fungus in some applicators. This affects the sterility of the product, which is critical for medical use. The affected lot is Lot #4032183 with an expiration date of January 31, 2027.
- 2026-07-01FDA-DrugCareFusion 213, LLCClass IIBD ChloraPrep FREPP Clear recalled for sterility risk
BD ChloraPrep FREPP Clear applicators may have wrinkles in the paper lid that could compromise the sterile seal. This affects multiple lot numbers distributed nationwide through mid-2027. No injuries have been reported.
- 2026-07-01FDA-DrugCareFusion 213, LLCClass IIBD ChloraPrep Clear recalled for sterility assurance concern
BD ChloraPrep Clear, a sterile skin antiseptic solution used before medical procedures, is being recalled because wrinkles in the paper packaging lid may allow the sterile seal to be breached. This defect could potentially allow contamination of the product. No injuries have been reported.
- 2026-07-01FDA-DrugPReye LLCClass IIPReye Vitamin See eye drops recalled for sterility concerns
PReye LLC is recalling all lots of PReye Vitamin See Antioxidant Preservative Free Eye Drops due to lack of assurance of sterility. The recall affects approximately 50 to 60 bottles distributed in Colorado. No injuries have been reported.
- 2026-07-01FDA-DrugANI Pharmaceuticals, Inc.Class IIIANI Pharmaceuticals hydroxyzine solution recalled for foreign substance
ANI Pharmaceuticals is recalling hydroxyzine hydrochloride oral solution (10 mg/5 mL, 473 mL bottles) due to the presence of a foreign substance in one lot. The affected product was distributed nationwide. No injuries have been reported.
- 2026-07-01FDA-DrugCentral Admixture Pharmacy Services, Inc.Class IICentral Admixture pediatric TPN bag missing required nutrients
Central Admixture Pharmacy Services issued a recall for one patient-specific Total Parenteral Nutrition (TPN) bag that did not contain copper and famotidine as listed on the label. The bag was prepared for a pediatric patient in Massachusetts. No injuries have been reported.
- 2026-07-01FDA-DrugDirect RxClass IIDirect Rx Duloxetine D/R recalled for impurity risk
Direct Rx's packaged Duloxetine D/R 30 mg capsules contain levels of N-nitroso-duloxetine, a potentially harmful impurity, above FDA's recommended limit. This is a manufacturing quality issue affecting specific lots distributed nationwide.
- 2026-07-01FDA-DrugAmgen, Inc.Class IIAmgen Sensipar cinacalcet tablets recalled for manufacturing deviations
Amgen is recalling Sensipar (cinacalcet) 90mg tablets due to deviations from current good manufacturing practice (CGMP) standards. This affects one lot distributed nationwide. No injuries have been reported.
- 2026-07-01FDA-DrugAmgen, Inc.Class IIAmgen Corlanor recalled for foreign substance contamination
Amgen is recalling specific lots of Corlanor (ivabradine) 7.5mg tablets due to the presence of a foreign substance in some bottles. The affected lots were distributed nationwide. No injuries have been reported.
- 2026-07-01FDA-DrugAmgen, Inc.Class IIAmgen Sensipar tablets recalled for manufacturing deviations
Amgen is recalling Sensipar (cinacalcet) 60mg tablets due to deviations from manufacturing standards. The recall affects one lot (1157055) with an expiration date of January 31, 2028, distributed nationwide.
- 2026-07-01FDA-DrugAmgen, Inc.Class IIAmgen Sensipar recalled for manufacturing quality deviations
Amgen is recalling Sensipar (cinacalcet) 30mg tablets due to deviations from manufacturing quality standards (CGMP). The recall affects one specific lot distributed nationwide. No injuries have been reported.
- 2026-07-01FDA-DrugAmgen, Inc.Class IIAmgen Corlanor heart medication recalled for foreign substance
Amgen has recalled multiple lots of Corlanor (ivabradine) 5 mg tablets due to the presence of a foreign substance in some bottles. The affected tablets are packaged in 14-tablet and 60-tablet bottles distributed nationwide. No injuries have been reported.
- 2026-07-01FDA-DrugAjanta Pharma USA IncClass IIAjanta Pharma fenofibrate capsules recalled for quality issues
Ajanta Pharma USA Inc. is recalling one lot of fenofibrate 200 mg capsules due to manufacturing quality deviations discovered during inspection. The affected lot (PA02216, expiring 12/2029) was distributed nationwide.
- 2026-07-01FDA-DrugThe Harvard Drug Group LLCClass IIMajor Pharmaceuticals Methylergonovine Maleate recalled for subpotency
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
- 2026-07-01NHTSA-EquipmentChrysler (FCA US, LLC)Chrysler (FCA US, LLC) - Parking & Daytime Running Lights May Fail/FMVSS 108
Parking lights and daytime running lights that fail to illuminate properly reduce the vehicle's visibility to other drivers, increasing the risk of a crash.